CompletedNCT00269776
Extended-release methylphenidate, Ritalin, or placebo for children with ADHD
About this title
Read the official source — NCT00269776Medication studyAges 6–12
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria applied.
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNovember 1998
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Alza Corporation, DE, USA
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Not clearly listed
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT00269776
- Official title
Show the full official title
Screening, Efficacy, and Safety Study Evaluating OROS (Methylphenidate HCl), Ritalin and Placebo in Children With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is Alza Corporation, DE, USA.
Did this study involve medication?
Yes. The study involved medication, including Placebo, OROS (methylphenidate HCl) and Ritalin (methylphenidate).
Who was this study for?
This study was for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria applied.
